- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 10 residues within 4Å:- Chain C: E.181, K.222, V.224, L.231, N.232, C.347, C.413, V.414, S.415
- Ligands: NAG-NAG.5
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:V.414
- Hydrogen bonds: C:V.414
NAG-NAG-BMA.10: 10 residues within 4Å:- Chain G: E.181, K.222, V.224, L.231, N.232, C.347, C.413, V.414, S.415
- Ligands: NAG-NAG.12
2 PLIP interactions:2 interactions with chain G- Hydrophobic interactions: G:V.414
- Hydrogen bonds: G:V.414
NAG-NAG-BMA.17: 10 residues within 4Å:- Chain K: E.181, K.222, V.224, L.231, N.232, C.347, C.413, V.414, S.415
- Ligands: NAG-NAG.19
2 PLIP interactions:2 interactions with chain K- Hydrophobic interactions: K:V.414
- Hydrogen bonds: K:V.414
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.22: 4 residues within 4Å:- Chain C: N.246, I.247, T.248
- Ligands: NAG.28
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain C: N.271, I.292, V.410
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain C: N.265, T.267, H.299, N.301, R.412
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain C: T.342, N.355, S.357, R.387
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain C: S.357, N.361
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.332, S.333, S.334
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain C: N.204, T.206, I.247
- Ligands: NAG.22
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain C: R.162, N.167, T.168
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain C: E.57, N.58
- Chain D: G.16, S.17
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain G: N.246, I.247, T.248
- Ligands: NAG.37
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain G: N.271, I.292, V.410
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain G: N.265, T.267, H.299, N.301, R.412
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain G: T.342, N.355, S.357, R.387
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain G: S.357, N.361
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain G: N.332, S.333, S.334
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain G: N.204, T.206, I.247
- Ligands: NAG.31
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain G: R.162, N.167, T.168
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain G: E.57, N.58
- Chain H: G.16, S.17
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain K: N.246, I.247, T.248
- Ligands: NAG.46
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain K: N.271, I.292, V.410
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain K: N.265, T.267, H.299, N.301, R.412
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain K: T.342, N.355, S.357, R.387
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain K: S.357, N.361
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain K: N.332, S.333, S.334
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain K: N.204, T.206, I.247
- Ligands: NAG.40
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain K: R.162, N.167, T.168
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain K: E.57, N.58
- Chain L: G.16, S.17
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nogal, B. et al., HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite. Sci Adv (2020)
- Release Date
- 2020-07-01
- Peptides
- 43A2 light chain: AEI
43A2 heavy chain: BFJ
Envelope glycoprotein gp120: CGK
Envelope glycoprotein gp41: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LE
JI
KB
HF
GJ
IC
AG
CK
DD
BH
EL
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nogal, B. et al., HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite. Sci Adv (2020)
- Release Date
- 2020-07-01
- Peptides
- 43A2 light chain: AEI
43A2 heavy chain: BFJ
Envelope glycoprotein gp120: CGK
Envelope glycoprotein gp41: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LE
JI
KB
HF
GJ
IC
AG
CK
DD
BH
EL
F